Article
The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study.
Metabolism: clinical and experimental - 1 Sept 2003
Schuster D, Gaillard T, Rhinesmith S, Habash D, Osei K
Abstract excerpt
African Americans (AA) have greater prevalence of type 2 diabetes mellitus (DM), and nondiabetic AA have demonstrated increased insulin resistance when compared with Caucasian Americans (CA). The objective of this study was to examine the impact of chronic use of an insulin sensitizer on glucose...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
